Comparison of depression risk and depression-related ambulatory care utilization in sarcopenia patients with and without Chinese herbal medicine

Table 2 Chinese herbal medicines use and risk of depression by the conditional logistic regression, n (%)

CHMs exposure	Subjects		Crude OR (95%CI)	Adjusted OR (95%CI)
	Cases (n = 1610)	Controls (n = 3230)
Non-CHMs users	993 (61.7)	1737 (53.9)	1	1
CHMs users	617 (38.3)	1483 (46.1)	0.72 (0.64-0.82)	0.71 (0.62-0.80)
Level 1 (< 1 year)	561 (34.8)	1237 (38.4)	0.79 (0.69-0.90)	0.77 (0.68-0.88)
Level 2 (1-3 years)	39 (2.4)	167 (5.2)	0.41 (0.28-0.58)	0.40 (0.28-0.57)
Level 3 (3 years or more)	17 (1.1)	79 (2.5)	0.37 (0.22-0.64)	0.35 (0.21-0.60)

Adjusted for potential confounders that included age, gender, residential area, monthly income and Charlson-Deyo Comorbidity Index. CHMs: Chinese herbal medicines; OR: Odds ratio; CI: Confidence intervals.